SCHEMBL4640632

SCHEMBL4640632

CCc1cc(C(=O)OC(CC)CCC(C)C)c(C(=O)OC(CC)CCC(C)C)cc1C

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.40
PRKCD Q05655 2/20 0.40
ADRA1A P35348 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
UTS2R Q9UKP6 1/20 0.31
SCN1A P35498 1/20 0.31
SCN2A Q99250 1/20 0.31
SCN3A Q9NY46 1/20 0.31
SHBG P04278 1/20 0.31
PPARG P37231 2/20 0.31
PPARD Q03181 2/20 0.31
PPARA Q07869 2/20 0.31
NPSR1 Q6W5P4 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRB2 P47870 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640664 0.95 PRKCA (0.36) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4640634 0.95 PRKCA (0.36) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4639861 0.91 PRKCA (0.43) PRKCAPRKCDADRA1AL3MBTL1UTS2R
SCHEMBL4641007 0.91 PRKCA (0.43) PRKCAPRKCDADRA1AL3MBTL1SCN1A
SCHEMBL4640933 0.88 PRKCA (0.51) PRKCAPRKCDL3MBTL1UTS2RSHBG
SCHEMBL4639878 0.88 PRKCA (0.41) PRKCAPRKCDPPARG
SCHEMBL4639863 0.86 PRKCA (0.40) PRKCAPRKCDADRA1AL3MBTL1UTS2R
SCHEMBL4641009 0.86 PRKCA (0.40) PRKCAPRKCDADRA1ASCN1ASCN2A
SCHEMBL4640536 0.84 PRKCA (0.39) PRKCAPRKCDADRA1AL3MBTL1UTS2R
SCHEMBL4639966 0.84 PRKCA (0.39) PRKCAPRKCDUTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX PRKCA 1200/4885PRKCD 552/4885ADRA1A 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.